Stocks and Investing
Stocks and Investing
Fri, July 22, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Brian Tanquilut Downgraded (AVAH) to Hold and Decreased Target to $2.5 on, Jul 22nd, 2022
Brian Tanquilut of Jefferies, Downgraded "Aveanna Healthcare Holdings Inc." (AVAH) to Hold and Decreased Target from $9 to $2.5 on, Jul 22nd, 2022.
Brian has made no other calls on AVAH in the last 4 months.
There are 8 other peers that have a rating on AVAH. Out of the 8 peers that are also analyzing AVAH, 3 agree with Brian's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- David Macdonald of "Truist Securities" Downgraded from Strong Buy to Hold on, Tuesday, July 5th, 2022
- Scott Fidel of "Stephens & Co." Downgraded from Buy to Hold and Decreased Target to $3.5 on, Tuesday, June 21st, 2022
- Joanna Gajuk of "B of A Securities" Downgraded from Strong Buy to Hold and Decreased Target to $5.5 on, Tuesday, March 29th, 2022
These are the ratings of the 5 analyists that currently disagree with Brian
- Ben Hendrix of "RBC Capital" Maintained at Buy with Decreased Target to $9 on, Thursday, March 31st, 2022
- John Ransom of "Raymond James" Maintained at Strong Buy with Decreased Target to $8 on, Thursday, March 31st, 2022
- Nick Giovacchini of "Credit Suisse" Maintained at Buy with Decreased Target to $9.5 on, Wednesday, March 30th, 2022
- Pito Chickering of "Deutsche Bank" Maintained at Strong Buy with Decreased Target to $6 on, Wednesday, March 30th, 2022
- Sarah James of "Barclays" Maintained at Buy with Decreased Target to $7 on, Wednesday, March 30th, 2022
Contributing Sources